Matt Fung is a senior analyst with a particular interest in pharmaceuticals at the NIHR Horizon Scanning Centre.
Matt has recently led on the re-development of the NIHR HSC’s information systems, and is also an active member of Oversight and Governance Committee, and Technical Sugroup of UK PharmaScan – a new national database to track new and emerging pharmaceutical products.
He currently leads engagement with pharmaceutical companies to identify significant developments likely to have an impact on the NHS in the next few years.
In addition to his pharmaceutical and system development work, Matt teaches medical students epidemiology and biostatistics. He has also presented a project on innovation in public health at a EuroScan meeting in Zurich and at HTAi conference in Singapore. The project was subsequently published in the Journal of Public Health in 2011.
Master of Public Health, University of Birmingham, 2008
Bachelor in Medical Science (Hons) (cell and molecular biology), University of Birmingham, 2005
Matt started at the NIHR HSC in 2006 as a research associate after graduating from his first degree in Medical Science. Shortly after starting at the NIHR HSC, he undertook a part time Master’s course in public health and graduated again in 2008. He was promoted in 2009 to a senior analyst which saw his role develop from predominantly writing technical reports for the Department of Health and National Institute for Health and Clinical Excellence (NICE), to focussing on leading the drugs sub team, leading engagement with the pharmaceutical industry and developing new IT systems, both locally and nationally. Matt regularly attends national meetings to discuss the appraisal of new pharmaceutical products where guidance to the NHS may ultimately be issued.
Dissertation projects that Matt has worked on for both his undergraduate degree in medical science and post graduate masters in public health have both been published in peer reviewed journals. His current research involves evaluating the last 10 years of horizon scanning.
Matt has presented at a number of international conferences and meetings, including Health Technology Assessment international (Singapore), Health Technology Assessment international (Montreal), EuroScan meeting in Zurich – Switzerland and a horizon scanning workshop in Bilbao - Spain.
10 years of horizon scanning in England (2011)
Identification of innovation in public health (2008)
Regulation of genes in nasopharyngeal carcinoma (2005).
Fung M, Simson S, Packer C. (2010), Identification of innovation in public health. J Public Health; doi: 10.1093/pubmed/fdq045
Bose S,Yap L-F, Fung M et al (2009), The ATM tumour suppressor gene is down-regulated in EBV-associated nasopharyngeal carcinoma. J Pathol, 217: 345–352